Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Indian IPO flood

At least six Indian hospital groups are planning to IPO within the next year. No one wants to jump first, but eventual valuations are likely to be strong, despite a fall in optimism surrounding healthcare stocks.
July 22, 2015

Woe is Greece?

It will come as no surprise that Greece’s healthcare system is under pressure, one that will worsen under new austerity measures. We take a look at what is happening and at a potential saving grace for operators.
July 16, 2015

Antin buys amedes as doctors walk

Antin Infrastructure Partners has bought General Atlantic’s majority stake in amedes, the big German lab and gynaecology specialist. This is not just Antin’s first healthcare service investment, but also its first investment in a people business. It could be a steep learning curve – we hear that many doctors are quitting amedes. We talk to amedes about future plans and the consolidation of the German outpatient sector.
July 13, 2015

Sri Lankan market growing at 15% per annum

The Sri Lankan healthcare market is growing at breakneck speed says director of Hemas Hospitals, Murtaza Esufally. Problems with the public system are driving patients towards the private sector.
July 8, 2015

Interview: Stefan Larsson, Senior Partner, BCG

Worldwide, Stefan Larsson foresees a strong move in healthcare away from fee for service, in which quality is not measured and rewarded, to a system which measures and rewards outcomes. He thinks that model will apply across acute, elderly and chronic care. But how real is the shift? Here we talk to Larsson about examples of operators who have seen significant growth and about how payors are about to shift away from DRGs. He is a Co-founder of the International Consortium for Health Outcomes Measurement (ICHOM), a not-for-profit devoted to the development of global standards for measurement of health outcomes that matter to patients.
July 8, 2015

Eurofins buys Biomnis

As forecast here, Eurofins Scientific is to buy French reference lab Biomnis and is also acquiring Bio-Access, a chain of 30 labs across France. The Biomnis acquisition marks the entry into the sector of a quoted industrial which is widely seen as an aggressive acquisition machine.
June 26, 2015

Cinven’s €3 billion bet on labs

Cinven has placed a €3bn bet on the European diagnostic laboratory space, by agreeing to pay a higher than expected €1.85bn for synlab Group, a multiple of just over 12 times current EBITDA. It will combine synlab with Labco to create a truly Pan-European lab group with pro-forma 2014 sales of just over €1.4bn, nearly twice that of its nearest rival. But why bet €3bn on a sector where tariffs are falling and operators have no control over pricing? And could the French authorities block the deal?
June 26, 2015

Zoom-zoom – the Chinese lab sector

Hospital outsourcing is one factor behind the meteoric growth of the Chinese lab sector. We give an overview of the sector and look at the drivers for growth.
June 23, 2015

Eurofins to buy Bio-Access – will Biomnis be next?

As forecast here, Eurofins Scientific is to enter the European medical diagnostic lab sector with the acquisition of Bio-Access. But the deal has little rationale, unless Eurofins also buys French reference lab Biomnis.
June 19, 2015
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us